Home > Product > Levetiracetam SR
| CATEGORY |
PRODUCT PROFILE |
| PRODUCT NAME |
Levetiracetam SR (Sustained Release) Tablet
(Original : Keppra XR Tablet from UCB)
|
| COMPANY |
Biopharmartis |
DEVELOPMENT
STATUS |
Finished fomulation study, BE simulation
(Strengths : 500mg, 750mg)
|
| THERAPEUTIC AREA |
Antiepileptics |
| ACTION |
Binds to a synaptic vesicle protein, SV2A |
| STRENGTH |
- Diffusion Matrix type SR formulation with identical multi-strength release profile
- Tablet formulation patent with non-infringement of original fomulation patent
(KR 2010-0116988, PCT will be available in Oct, 2011)
- Identical mechanism in simulatied gastric fluid compared with original product
(Consider BE test in fed mode)
- Simplified manufacturing process = Low manufacturing cost
|
| TECHNOLOGY |
SR Platform |
